The rating reflects Partners’ exceptional enterprise profile, including its preeminent research program and tertiary and quaternary offerings, while also taking into account the abrupt resignation of CEO David Torchiana, MD.
The rating outlook is stable.
More articles on healthcare finance:
Moody’s affirms “MIG 2” for Yukon-Kuskokwim Health Corp
HCA more than doubles profit in Q4
Emergency physicians propose 6-point plan to end balance billing
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
